Igny, 1
er
June 2022 – Medical Devices Venture, subsidiary of ARCHOS in investment and acceleration in MedTech, announces the entry of a new investor in the capital of Poladerme.
The entry into the capital of Poladerme (approximately 9%) of the Wongs group, through its subsidiary Top Plenty Ltd, is part of Poladerme’s business development strategy with the preparation of a distribution network for Poladerme products. The Wong Group is a major Hong Kong player in new technologies, real estate development and strategic investments. The Wongs Group invests in various sectors including new technologies and health. He identified in Poladerme an innovative dermatological solution, adapted to the needs of the market.
Loïc Poirier, President of Poladerme declares “We are proud to count the Wongs group among the shareholders of Poladerme. This group is developing many activities in Asia and we intend to conclude a distribution contract with WONGS for Poladerme products in this region, which pays particular attention to activities dealing with dermatology and cosmetics. This entry into the capital of Poladerme is also a guarantee of confidence in the relevance of the project and will accelerate development outside Europe as soon as we enter the marketing phase.”
POLADERME: artificial intelligence at the service of dermatology and cosmetology
Poladerm
whose ambition is to become a leader in spectropolarimetry, combined with Artificial Intelligence and Machine Learning, applied to dermatology is the result of more than 10 years of research on spectropolarimetry and treatment and image analysis conducted by professors Jihad Zallat and Christian Heinrich.
Poladerme, matured by Conectus, the Strasbourg SATT, is developing an innovative, rapid and non-invasive diagnostic aid solution, based on an optical system and Artificial Intelligence algorithms to analyze tissues in depth and assess the state of skin health. This innovative tool will use what should become a database of medical polarimetric images that is unique in the world, thus improving its analysis power with each new image.
Contact :
Loic POIRIER –
CEO ARCHOS – [email protected]
About ARCHOS
ARCHOS, an expert in mobile solutions, has constantly revolutionized this market both in the consumer electronics sector and in B to B with its subsidiary Logic Instrument. The French brand was thus the first to offer Google Android tablets in 2009. Today, ARCHOS designs and democratizes products with high innovation value and in 2021 created a MedTech division, Medical Devices Venture, which will bring together several startups. With a head office in France, offices in Europe and Asia, ARCHOS is asserting itself as a key pan-European player, listed on the Euronext Growth Paris market, ISIN Code: FR0000182479. www.archos.com
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
m5hyYsmcZG/Kx26faZtramOVmGtixGbKaGmXyGWaZMuYZ5uUyZtpbZiWZnBlnWdu
– To check this key:
https://www.security-master-key.com.
Unregulated information:
Full and original press release in PDF format:
https://www.actusnews.com/news/74828-archos_-nouvel-investor-au-capital-de-poladerme_juin-2022.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com